Kolarík J, Nádvorník P, Tabarka K, Dvorák M, Rozhold O
Research Institute of Higher Nervous Activity, Palacký University, Olomoue, Czechoslovakia.
Zentralbl Neurochir. 1988;49(3):147-50.
Inspired by current knowledge of the possible participation of monoamines in the origin of schizophrenia and by experimental experience with embryonic nerve tissue transplantations, the authors ventured implantation of a human embryo's nervous tissue into a schizophrenic's brain. Six cubic millimeters of the transplant were placed in the septal area of both hemispheres. The substantial improvement of the clinical picture and, particularly, distinct improvement of memory abilities in the patient can more likely be attributed to the effect of the transplant rather than to the simultaneous mechanical intervention in the target structure of the recipient's brain.
受当前关于单胺类物质可能参与精神分裂症发病机制的知识启发,以及胚胎神经组织移植实验经验的影响,作者尝试将人类胚胎神经组织植入一名精神分裂症患者的大脑。6立方毫米的移植组织被置于双侧半球的隔区。患者临床症状的显著改善,尤其是记忆能力的明显提高,更可能归因于移植组织的作用,而非同时对受体大脑目标结构进行的机械干预。